Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10018757HBVENSG00000127022.16protein_codingCANXNoNo821P27824
TVIS30008946HIVENSG00000127022.16protein_codingCANXNoNo821P27824
TVIS30008947HIVENSG00000127022.16protein_codingCANXNoNo821P27824
TVIS30008948HIVENSG00000127022.16protein_codingCANXNoNo821P27824
TVIS30016348HIVENSG00000127022.16protein_codingCANXNoNo821P27824
TVIS30004913HIVENSG00000127022.16protein_codingCANXNoNo821P27824
TVIS30003786HIVENSG00000127022.16protein_codingCANXNoNo821P27824
TVIS30008949HIVENSG00000127022.16protein_codingCANXNoNo821P27824
TVIS30082060HIVENSG00000127022.16protein_codingCANXNoNo821P27824
TVIS30084733HIVENSG00000127022.16protein_codingCANXNoNo821P27824
TCGA Plot Options
Drug Information
GeneCANX
DrugBank IDDB00031
Drug NameTenecteplase
Target IDBE0001011
UniProt IDP27824
Regulation Type
PubMed IDs9359841
CitationsAllen S, Bulleid NJ: Calnexin and calreticulin bind to enzymically active tissue-type plasminogen activator during biosynthesis and are not required for folding to the native conformation. Biochem J. 1997 Nov 15;328 ( Pt 1):113-9.
GroupsApproved
Direct ClassificationPeptides
SMILES
PathwaysTenecteplase Action Pathway
PharmGKBPA164776757
ChEMBLCHEMBL2108791